ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$9.63
-1.78%
Mkt Cap $2.27B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
Implied Upside
+93.9%
Consensus $18.67 vs current $9.63
NASDAQ·Healthcare·Biotechnology
$9.63
-1.78%
Mkt Cap $2.27B
Buy
4
Hold
0
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
+93.9%
Consensus $18.67 vs current $9.63